Calcium pills improve nelfinavir diarrhoea

This article is more than 23 years old.

Calcium tablets taken twice daily appear to have a dramatic impact on nelfinavir-related diarrhoea, doctors from Texas reported at last week's ICAAC conference in San Francisco.

A small 15 person open-label study tested the effectiveness of 500mg calcium twice daily in patients reporting nelfinavir-related diarrhoea which had been poorly controlled with standard anti-diarrhoeal medications. 40% had grade 1 diarrhoea, 47% grade 2 and 13% grade 3 (severe). After a minimum of 48 hours calcium treatment, all reported significant improvement in their symptoms as measured by 6 parameters. 87% reported normal stools and 13% reported grade 1 diarrhoea.

A study of psyllium husk fibre bars for the control of PI-associated diarrhoea reported similar encouraging results. 13/14 individuals reported improved symptoms after taking two bars one hour before bedtime; the mean severity of diarrhoea declined from grade 1.78 (verging on moderate) at baseline to 0.93 (mild) after two weeks, and the treatment was well tolerated.

Glossary

diarrhoea

Abnormal bowel movements, characterised by loose, watery or frequent stools, three or more times a day.

protease inhibitor (PI)

Family of antiretrovirals which target the protease enzyme. Includes amprenavir, indinavir, lopinavir, ritonavir, saquinavir, nelfinavir, and atazanavir.

open-label

A clinical trial where both the researcher and participants know who is taking the experimental treatment. 

efficacy

How well something works (in a research study). See also ‘effectiveness’.

References

Perez-Rodriguez E et al. The role of calcium supplements in the treatment of nelfinavir-associated diarrhoea. 39th ICAAC, San Francisco, abstract 1308, 1999.

Ronagh T et al. Psyllium husk fibre bars are efficacious in the treatment of protease inhibitor (PI)-induced diarrhoea. 39th ICAAC, San Francisco, abstract 1307, 1999.